NISAN - The National Institute for Stroke and Applied Neurosciences

AUT Main Nav
Centre Banner
Main Content

The National Institute for Stroke and Applied Neurosciences

The primary aim of NISAN is to conduct high quality epidemiological studies and clinical trials to improve the health and outcomes in people with major neurological disorders. Our current research programmes focus on:

  • stroke
  • traumatic brain injury
  • neuromuscular disorders

Research with this aim is unique within the landscape of existing research groups in New Zealand.

NISAN is envisaged to be a hub for information sharing and the fostering of a more cohesive network of communication between existing research and clinical groups with interests in neuroepidemiology, public health, neurorehabilitation, neuropsychology and biostatistics.

This direction allows a cohesive approach to communicating and working collaboratively with other groups, both within and outside AUT. NISAN makes use of the current expertise within the School of Clinical Sciences, the School of Public Health and Psychosocial Studies, and relevant institutes and centres at AUT, and it extends their work into areas of growing national and international demand.

Recent developments

Currently available cardiovascular disease (CVD) risk assessment algorithms allow calculation of absolute risk of CVD (including stroke) but they are designed for use by health professionals and require a lab test to complete. One of the main challenges in effective stroke prevention for an individual is the lack of awareness about stroke symptoms and risk factors, as well as self-managing strategies to reduce their risk of stroke.

To help improve stroke prevention in individuals with an increased CVD risk in the most efficient way, we developed an App called Stroke Riskometer which has the potential to significantly improve stroke prevention on an individual level. The Stroke Riskometer is able to calculate your risk through evaluating a series of risk factors such as age, gender, ethnicity, lifestyle and other health factors that directly influence your likelihood of a stroke within the next 5 and 10 years.

Importantly, the Stroke Riskometer user can find out both  their risk of stroke development and also a baseline risk to compare their risk against, thus allowing them to know their risk of stroke compared with someone of their age and sex who has no risk factors.

Developed in collaboration with international leaders in stroke prevention, Stroke Riskometerâ„¢ app is an award winning and easy-to-use tool for measuring your individual risk of a stroke in the next five to ten years. The Pro version will also supply essential information on how you can reduce the chance of stroke.

You can also elect to join an international research study, RiBURST, where you can submit your data to help us better understand stroke, its risk factors and develop global prevention strategies.

The information presented in the Stroke Riskometer has been developed by Professor Valery Feigin (MD, MSc, PhD, FAAN), Director of the National Institute for Stroke and Applied Neurosciences, AUT, New Zealand.
Last updated: 09 Jul 2014 2:05pm

Auckland University of Technology, New Zealand | Copyright © | Privacy | Site map

AUT News Area
Apr 23rd, 2015

NZANC Conference

The New Zealand Applied Neurosciences Conference is held in Auckland, New Zealand.  The next conference will be in September 2016.  Watch this space for more information.

Feigin, V.L., Krishnamurthi, et al on behalf of the Global Burden of Diseases, Injuries, and Risk Factors Study (the GBD 2010 Study) and the GBD Stroke Experts Group* Global and regional burden of stroke in 1990-2010:  incidence, mortality, prevalence, and disability-adjusted life-years lost. The Lancet 2013.
Dec 16th, 2014

Braden Te Ao
Area of expertise: Health Services Research and Health Economics
Qualification: MPH (hons), PGDip PH, BHSc. PhD Student.